Endocrine & Diabetes

GLP-1 Receptor Agonists

Semaglutide, Tirzepatide, Liraglutide — diabetes & weight management therapies

6 common products4 with a HCPCS code
At a glance

GLP-1 Receptor Agonists include Ozempic, Mounjaro, Wegovy, Zepbound. Clinician-administered products in this class bill under J3490; the rest are dispensed by a pharmacy and billed on the NDC alone.

Common products in this class

OzempicMounjaroWegovyZepboundVictozaRybelsus

Billing codes for this class

HCPCS codes for GLP-1 Receptor Agonists
DrugCodeBillable unit
OzempicJ3490Per multi-dose pen (2 mg / 4 mg / 8 mg)
MounjaroJ3490Per single-dose pen
WegovyJ3490Per single-dose pen
ZepboundJ3490Per single-dose pen

FDA records in this class

NDC 0002-1484RxMounjaroLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0169-4130RxOzempicLabelerNovo Nordisk Pharmaceutical Industries, LPFormInjection, solutionView details NDC 0002-6304RxZepboundLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 71288-563RxLiraglutideLabelerMeitheal Pharmaceuticals Inc.FormInjectionView details NDC 0480-7250RxLiraglutideLabelerTeva Pharmaceuticals, Inc.FormInjection, solutionView details NDC 0002-3422RxMounjaro KwikPenLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0002-3455RxMounjaro KwikPenLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0002-3522RxZepbound KwikPenLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0002-1433RxTrulicityLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0002-1214RxZepboundLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0002-3555RxZepbound KwikPenLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0169-4060RxVictozaLabelerNovo NordiskFormInjectionView details NDC 0002-4052RxMounjaroLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0002-1457RxMounjaroLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0002-2236RxTrulicityLabelerEli Lilly and CompanyFormInjection, solutionView details NDC 0169-4181RxOzempicLabelerNovo Nordisk Pharmaceutical Industries, LPFormInjection, solutionView details NDC 50090-7589RxTrulicityLabelerA-S Medication SolutionsFormInjection, solutionView details NDC 81607-018RxLiraglutideLabelerOrbicular Pharmaceutical Technologies Private LimitedFormInjection, solutionView details NDC 50090-2853RxVictozaLabelerA-S Medication SolutionsFormInjectionView details NDC 0002-2423RxMounjaroLabelerEli Lilly and CompanyFormInjection, solutionView details

Next steps

Every NDC in this class

The full FDA registry filtered to glp-1 receptor agonists, with packaging and billing crosswalks.

Open the directory

Trials in this area

Treatments still in Phase 1 to 3 for the same therapeutic area.

View the pipeline

Other classes

HMG-CoA Reductase Inhibitors (Statins)SGLT2 InhibitorsMonoclonal Antibodies / ImmunotherapiesBeta-Adrenergic BlockersNonsteroidal Anti-inflammatory Drugs (NSAIDs)CNS Stimulants & ADHD AgentsSSRIs & Antidepressants
All drug classes